Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Eye scans could predict vision loss in diabetes patients

NCT ID NCT04636307

First seen Jan 05, 2026 · Last updated Jun 18, 2026 · Updated 22 times

Summary

This study looked at 202 adults with type 2 diabetes and early-stage diabetic eye disease (non-proliferative diabetic retinopathy). Researchers used non-invasive eye scans to find markers that could predict if the disease would get worse or lead to sight-threatening problems. The goal was to better understand how the retina changes over time, without any treatment being tested.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CS001 Centre for Clinical Trials - AIBILI

    Coimbra, Portugal

  • CS020 - G. B. Bietti Eye Foundation - IRCCS

    Roma, Italy

  • CS042 - Department of Ophthalmology, University Hospital, CHU Dijon

    Dijon, France

  • CS063 - Excellence Eye Research Centre, University G. d'Annunzio of Chieti-Pescara

    Pescara, Italy

  • CS067- Department of Ophthalmology, University Vita Salute - Scientific Institute of San Raffael, Milan

    Milan, Italy

Conditions

The condition(s) this trial relates to.

background diabetic retinopathy retinal disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.